Timothy Coughlin insider trades: Travere Therapeutics (TVTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Timothy reports to the SEC
and 2 more companies
Open-market buys and sales
36 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | TVTX | ↓ Sell | 10,000 | $50.07 | $501K | Direct | Jun 16, 2026 (4d) |
| May 15, 2026 | TVTX | ↓ Sell | 3,250 | $43.49 | $141K | Direct | May 19, 2026 (4d) |
| Oct 31, 2025 | TVTX | ↓ Sell | 18,000 | $35.03 | $631K | Direct | Nov 4, 2025 (4d) |
| May 30, 2024 | LIFE | ↑ Buy | 50,000 | $1.75 | $88K | Indirect | Jun 3, 2024 (4d) |
| Jun 3, 2022 | FATE | ↓ Sell | 1,439 | $22.81 | $33K | Direct | Jun 6, 2022 (3d) |
| Feb 6, 2017 | NBIX | ↓ Sell | 963 | $43.14 | $42K | Direct | Feb 8, 2017 (2d) |
| Feb 3, 2017 | NBIX | ↓ Sell | 1,500 | $42.55 | $64K | Direct | Feb 6, 2017 (3d) |
| Jan 17, 2017 | NBIX | ↓ Sell | 1,750 | $40.65 | $71K | Direct | Jan 18, 2017 (1d) |
| Jan 10, 2017 | NBIX | ↓ Sell | 1,750 | $43.37 | $76K | Direct | Jan 12, 2017 (2d) |
| Nov 23, 2016 | FATE | ↑ Buy | 56,390 | $2.66 | $150K | Direct | Nov 28, 2016 (5d) |
| Feb 3, 2016 | NBIX | ↓ Sell | 1,500 | $38.06 | $57K | Direct | Feb 4, 2016 (1d) |
| Jan 19, 2016 | NBIX | ↓ Sell | 1,750 | $46.69 | $82K | Direct | Jan 21, 2016 (2d) |
| Jan 11, 2016 | NBIX | ↓ Sell | 1,750 | $44.25 | $77K | Direct | Jan 13, 2016 (2d) |
| Oct 16, 2015 | NBIX | ↓ Sell | 25,000 | $47.78 | $1.2M | Direct | Oct 19, 2015 (3d) |
| Jul 20, 2015 | NBIX | ↓ Sell | 20,000 | $55.00 | $1.1M | Direct | Jul 21, 2015 (1d) |
| Jul 13, 2015 | NBIX | ↓ Sell | 20,000 | $50.00 | $1.0M | Direct | Jul 14, 2015 (1d) |
| Jun 8, 2015 | NBIX | ↓ Sell | 60,000 | $45.08 | $2.7M | Direct | Jun 10, 2015 (2d) |
| Mar 20, 2015 | NBIX | ↓ Sell | 40,000 | $44.49 | $1.8M | Direct | Mar 24, 2015 (4d) |
| Jan 16, 2015 | NBIX | ↓ Sell | 1,750 | $30.81 | $54K | Direct | Jan 21, 2015 (5d) |
| Jan 12, 2015 | NBIX | ↓ Sell | 1,750 | $28.37 | $50K | Direct | Jan 13, 2015 (1d) |
| Jan 8, 2015 | NBIX | ↓ Sell | 10,000 | $27.25 | $273K | Direct | Jan 9, 2015 (1d) |
| Dec 19, 2014 | NBIX | ↓ Sell | 30,000 | $23.46 | $704K | Direct | Dec 19, 2014 (0d) |
| Dec 10, 2014 | NBIX | ↓ Sell | 20,000 | $21.48 | $430K | Direct | Dec 12, 2014 (2d) |
| Nov 28, 2014 | NBIX | ↓ Sell | 10,000 | $20.14 | $201K | Direct | Dec 2, 2014 (4d) |
| Oct 31, 2014 | NBIX | ↓ Sell | 10,000 | $19.00 | $190K | Direct | Nov 3, 2014 (3d) |
| Oct 30, 2014 | NBIX | ↓ Sell | 20,000 | $18.31 | $366K | Direct | Oct 30, 2014 (0d) |
| Jan 10, 2014 | NBIX | ↓ Sell | 1,750 | $18.56 | $32K | Direct | Jan 13, 2014 (3d) |
| Jan 7, 2014 | NBIX | ↓ Sell | 70,000 | $16.75 | $1.2M | Direct | Jan 8, 2014 (1d) |
| Aug 21, 2013 | NBIX | ↓ Sell | 19,035 | $15.05 | $286K | Direct | Aug 22, 2013 (1d) |
| Aug 5, 2013 | NBIX | ↓ Sell | 10,965 | $14.99 | $164K | Direct | Aug 7, 2013 (2d) |
| Feb 28, 2011 | NBIX | ↓ Sell | 12,320 | $6.83 | $84K | Direct | Mar 2, 2011 (2d) |
| Mar 1, 2010 | NBIX | ↓ Sell | 12,650 | $2.53 | $32K | Direct | Mar 3, 2010 (2d) |
| Jan 12, 2010 | NBIX | ↓ Sell | 8,697 | $2.52 | $22K | Direct | Jan 13, 2010 (1d) |
| Mar 30, 2009 | NBIX | ↓ Sell | 12,117 | $3.43 | $42K | Direct | Apr 1, 2009 (2d) |
| Jan 13, 2009 | NBIX | ↓ Sell | 8,463 | $3.39 | $29K | Direct | Jan 15, 2009 (2d) |
| Feb 12, 2008 | NBIX | ↓ Sell | 7,857 | $5.02 | $39K | Direct | Feb 14, 2008 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TVTX insiders
Open-market trades in the last 12 months
About Timothy Coughlin's insider trades
Timothy Coughlin is an insider at Travere Therapeutics (TVTX). Since Feb 12, 2008, Timothy has reported 2 open-market purchases worth $237K and 34 sales worth $13.7M on SEC Form 4. In the last 12 months: 2 sales ($642K).
Their filings also include grants and awards (46 filings), option exercises (16 filings), shares withheld for taxes (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TVTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.